Article Data

  • Views 1033
  • Dowloads 148

Original Research

Open Access

The use of lymphadenectomy in clinical stage I endometrial adenocarcinoma at a large community hospital

  • C. A. Strittmatter1
  • M. Steven Piver1,*,

1Department of Obstetrics and Gynecology, Sisters of Charity Hospital, Buffalo, NY, USA

DOI: 10.12892/ejgo200105315 Vol.22,Issue 5,September 2001 pp.315-318

Published: 10 September 2001

*Corresponding Author(s): M. Steven Piver E-mail:

Abstract

PURPOSE AND MATERIALS AND METHODS: Because of the inaccuracies in clinical staging of endometrial cancer, the International Federation of Gynecology and Obstetrics (FIGO) in 1988 changed the staging of endometrial cancer to surgical staging consisting of intraoperative findings and histologic evaluation of the specimen. A decade later, 1998, the United States Society of Gynecologic Oncologists published Practice Guidelines for the surgical staging of endometrial cancer. The purpose of this study was to review the use of lymph node sampling and peritoneal washings in 100 consecutive cases of clinical stage I endometrial cancer and compare these results to the Practice Guidelines of the Society of Gynecologic Oncologists.

Results: The vast majority of patients (86%) had peritoneal washings and frozen section (69%) of the uterus. However, only slightly more than half (52%) had palpitation of the pelvic and/or para-aortic lymph nodes. Most encouraging and consistent with the Society of Gynecologic Oncologists' Guidelines is that 87% of the patients with histologically more aggressive cancers (grade III or deep myometrial invasion), had lymph node sampling as did 90.5% with more aggressive histologic subtypes.

Conclusion: Notwithstanding these results, there is still the need in the 21st century for more uniform guidelines for the surgical staging of endometrial cancer.

Keywords

Endometrial cancer; Staging; Lymph nodes

Cite and Share

C. A. Strittmatter,M. Steven Piver. The use of lymphadenectomy in clinical stage I endometrial adenocarcinoma at a large community hospital. European Journal of Gynaecological Oncology. 2001. 22(5);315-318.

References

[1] Greenlee R. T.,HilI-Harmon B., Murray T., Thun M.: "Cancer Statistics 2001". CA, 2001, 51, 15.

[2] FIGO Stages 1888 Rev几ion: Gynecologic Oncology, 1989, 35, 125.

[3] Ng A., Reagan J. W.: "Incidence and prognosis of endometrial carcinoma by histologic grade and extent". Obstet. & Gynecol., 1970, 35, 437.

[4] Lewis B. V., Stallworthy J. A., Cowdel R.: "Adenocarcinoma of the body of the uterus". J. Obstet. Gynaecol. of the Brit. Commonwealth, 1970, 77, 343.

[5] Creasman W. T., Boronow R. C., Morrow C. P.,D iSaia P. J., Blessing J.: "Ade nocarcinoma of the endometrium: It's metastatic lymph node potential. Preliminary report". Gynecol Oncol., 1976, 4, 239.

[6] Practice guidelines: "Uterine corpus-endometrial cancer". Oncology, 1998, 12, 122.

[7] Girardi F.,P etru E.,H eydarfadai M.,H aas J.,W inter R.: "Pelvic lymphadenectomy in the surgical treatment of endometrial cancer" Gynecol. Oncol., 1993, 49, 177.

Submission Turnaround Time

Top